Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1080157, 10 pages
https://doi.org/10.1155/2017/1080157
Research Article

MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source

1Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa
2Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
3Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
4Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg 7505, South Africa
5Department of Biochemistry and Microbiology, University of Zululand, Kwa-Dlangezwa 3886, South Africa

Correspondence should be addressed to C. Pheiffer; az.ca.crm@reffiehp.nemrac

Received 25 January 2017; Revised 28 March 2017; Accepted 10 April 2017; Published 26 April 2017

Academic Editor: Lan-Tao Gou

Copyright © 2017 S. Dias et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization and International Diabetes Federation (2006), Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of A WHO/IDF Consultation, IDF Consult, 2008.
  2. World Health Organization, “WHO methods and data sources for country-level causes of death 2000–2012,” Global Health Estimates Technical Paper, Department of Health Statistics and Information Systems, World Health Organization, Geneva, Switzerland, 2014. View at Google Scholar
  3. S. L. Fernandez-Valverde, R. J. Taft, and J. S. Mattick, “MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications,” Diabetes, vol. 60, no. 7, pp. 1825–1831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Tripathy and A. O. Chavez, “Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus,” Current Diabetes Reports, vol. 10, no. 3, pp. 184–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. G. Araújo, A. G. Oliveira, and M. J. A. Saad, “Insulin-resistance-associated compensatory mechanisms of pancreatic beta cells: a current opinion,” Frontiers in Endocrinology, vol. 4, article 146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, “Principles of microRNA-target recognition.,” PLoS Biology, vol. 3, no. 3, p. e85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Cheng and C. Zhang, “MicroRNA-21 in cardiovascular disease,” Journal of Cardiovascular Translational Research, vol. 3, no. 3, pp. 251–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Cuk, M. Zucknick, J. Heil et al., “Circulating microRNAs in plasma as early detection markers for breast cancer,” International Journal of Cancer, vol. 132, no. 7, pp. 1602–1612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhou, R. Peng, T. Li et al., “A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy,” Gene, vol. 527, no. 2, pp. 456–461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Kong, J. Zhu, W. Han et al., “Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study,” Acta Diabetologica, vol. 48, no. 1, pp. 61–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Santovito, V. De Nardis, P. Marcantonio et al., “Plasma exosome MicroRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 9, pp. E1681–E1685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Turchinovich, L. Weiz, and B. Burwinkel, “Extracellular miRNAs: the mystery of their origin and function,” Trends in Biochemical Sciences, vol. 37, no. 11, pp. 460–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Krek, D. Grün, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein et al., “Combinatorial microRNA target predictions,” Nature Genetics, vol. 37, no. 5, pp. 495–500, 2005. View at Publisher · View at Google Scholar
  14. K. Wang, Y. Yuan, J.-H. Cho, S. McClarty, D. Baxter, and D. J. Galas, “Comparing the MicroRNA spectrum between serum and plasma,” PLoS ONE, vol. 7, no. 7, Article ID e41561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Chen, J. A. L. Gelfond, L. M. McManus, and P. K. Shireman, “Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis,” BMC Genomics, vol. 10, article 1471, p. 407, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Pritchard, E. Kroh, B. Wood, J. D. Arroyo, K. J. Dougherty, M. M. Miyaji et al., “Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies,” Cancer Prevention Research, vol. 5, no. 3, pp. 492–497, 2012. View at Publisher · View at Google Scholar
  17. Statistics South Africa, Census 2011 Statistical Release, Statistics South Africa, Pretoria, South Africa, 2012.
  18. R. T. Erasmus, D. J. Soita, M. S. Hassan et al., “High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: baseline data of a study in Bellville, Cape Town,” South African Medical Journal, vol. 102, no. 11, pp. 841–844, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Andersen, J. L. Jensen, and T. F. Ørntoft, “Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets,” Cancer Research, vol. 64, no. 15, pp. 5245–5250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Agarwal, G. W. Bell, J.-W. Nam, and D. P. Bartel, “Predicting effective microRNA target sites in mammalian mRNAs,” eLife, vol. 4, Article ID e05005, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Betel, A. Koppal, P. Agius, C. Sander, and C. Leslie, “Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites,” Genome Biology, vol. 11, no. 8, article R90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Oliveros and C. Venny, An interactive tool for comparing lists with Venn Diagrams, 2007.
  23. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society, Series B: Methodological, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar · View at MathSciNet
  24. V. Rottiers and A. M. Näär, “MicroRNAs in metabolism and metabolic disorders,” Nature Reviews Molecular Cell Biology, vol. 13, no. 5, pp. 239–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. K. Pandey, P. Agarwal, K. Kaur, and M. Datta, “MicroRNAs in diabetes: Tiny players in big disease,” Cellular Physiology and Biochemistry, vol. 23, no. 4–6, pp. 221–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Motameny, S. Wolters, P. Nürnberg, and B. Schumacher, “Next generation sequencing of miRNAs—strategies, resources and methods,” Genes, vol. 1, no. 1, pp. 70–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Git, H. Dvinge, M. Salmon-Divon et al., “Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression,” RNA, vol. 16, no. 5, pp. 991–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Pritchard, H. H. Cheng, and M. Tewari, “MicroRNA profiling: approaches and considerations,” Nature Reviews Genetics, vol. 13, no. 5, pp. 358–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Zampetaki, S. Kiechl, I. Drozdov et al., “Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes,” Circulation Research, vol. 107, no. 6, pp. 810–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Balasubramanyam, S. Aravind, K. Gokulakrishnan et al., “Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 197–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Schöler, C. Langer, and F. Kuchenbauer, “Circulating microRNAs as biomarkers—true blood?” Genome Medicine, vol. 3, no. 11, p. 72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Zhu and S. W. Leung, “Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies,” Diabetologia, vol. 58, no. 5, pp. 900–911, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Færch, A. Hulmán, and T. P. J. Solomon, “Heterogeneity of pre-diabetes and type 2 diabetes: Implications for prediction, prevention and treatment responsiveness,” Current Diabetes Reviews, vol. 12, no. 1, pp. 30–41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. W.-Y. Lo, H.-J. Wang, C.-W. Chiu, and S.-F. Chen, “miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study,” Journal of Proteomics, vol. 77, pp. 154–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Wang, Y. Song, Y. Zhang, H. Xiao, Q. Sun, N. Hou et al., “Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice,” Cell Research, vol. 22, no. 3, pp. 516–527, 2012. View at Publisher · View at Google Scholar
  36. M. Karbiener, C. Fischer, S. Nowitsch et al., “microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ,” Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 247–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Li, H. Cao, J. Zhuang et al., “Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans,” Clinica Chimica Acta, vol. 412, no. 1-2, pp. 66–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. L. B. Nielsen, C. Wang, K. Sørensen et al., “Erratum to 'Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression',” Experimental Diabetes Research, vol. 2012, Article ID 672865, 1 page, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. van de Bunt, K. J. Gaulton, L. Parts et al., “The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis,” PLoS ONE, vol. 8, no. 1, Article ID e55272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-M. Wang, J. Tao, D.-D. Chen et al., “MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 1, pp. 99–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Kong, J. Yu, J. Bi et al., “Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue,” Diabetes, vol. 64, no. 2, pp. 393–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. K. C. Vickers, B. M. Shoucri, M. G. Levin et al., “MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia,” Hepatology, vol. 57, no. 2, pp. 533–542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Pescador, M. Pérez-Barba, J. M. Ibarra, A. Corbatón, M. T. Martínez-Larrad, and M. Serrano-Ríos, “Serum circulating microrna profiling for identification of potential type 2 diabetes and obesity biomarkers,” PLoS ONE, vol. 8, no. 10, Article ID e77251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. S. Karolina, A. Armugam, S. Tavintharan et al., “MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus,” PLoS ONE, vol. 6, no. 8, Article ID e22839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Yang, H. Chen, H. Si et al., “Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes,” Acta Diabetologica, vol. 51, no. 5, pp. 823–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Ezaki, “IIb group metal ions (Zn2+, Cd2+, Hg2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes,” Journal of Biological Chemistry, vol. 264, no. 27, pp. 16118–16122, 1989. View at Google Scholar · View at Scopus
  47. S. A. Myers, A. Nield, and M. Myers, “Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 173712, 13 pages, 2012. View at Publisher · View at Google Scholar
  48. R. W. A. Mackenzie and B. T. Elliott, “Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 7, pp. 55–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Itoh, S. Sakaue, H. Nakagawa et al., “Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 4, pp. E1069–E1077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. X.-Q. Liu, L. Wu, and X.-J. Guo, “Effect of Bu-Zhong-Yi-Qi-Tang on deficiency of N-glycan/nitric oxide and islet damage induced by streptozotocin in diabetic rats,” World Journal of Gastroenterology, vol. 15, no. 14, pp. 1730–1737, 2009. View at Publisher · View at Google Scholar · View at Scopus